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Background and Study Aims. Capsule endoscopy is an established tool for investigation of the small intestine. Because of limited
clinical experience in patients with cardiac devices, the Food and Drug Administration and the manufacturer recommended not
to use capsule endoscopy in these patients. The vast majority of investigations did not reveal any interference between capsule
endoscopy and cardiac devices. Methods. Studies investigating interference between CE and cardiac devices were analysed. For the
review we considered studies published in English or German and indexed in Medline, as well as highly relevant abstracts. Results.
In vitro and in vivo studies mainly revealed no interference between capsule endoscopy and cardiac devices. Technical data of
capsule endoscopy (Given Imaging) reveal that interference with cardiac pacemakers and implantable cardioverter deﬁbrillator
is impossible. Telemetry can interfere with CE video. Conclusion. The clinical use of capsule endoscopy (Given Imaging) is
unproblematic in patients with cardiac pacemakers.
1.Introduction
Capsule endoscopy (CE) is an established tool for inves-
tigation of the small intestine. Because of limited clinical
experience of CE in patients with cardiac pacemaker (PM)/
implantable cardioverter-deﬁbrillators (ICDs), the Food and
Drug Administration, as well the manufacturers Given
Imaging and Olympus, recommended not using CE in these
patients. The vast majority of published investigations did
not reveal any interference between small bowel capsule
endoscopy (Given Imaging Ltd., Yogneam, Israel; Olympus
Medical Systems Corp., Tokyo, Japan), Pill Cam Colon
(Given Imaging Ltd., Yogneam, Israel) on the one hand,
and cardiac pacemakers and ICD on the other hand. For
this paper we considered studies published in German or
EnglishandindexedinMedlineandcurrentabstractsofhigh
relevance.
2. Capsule Endoscopy in Patients with
CardiacPacemakers
Interference between capsule endoscopy and cardiac pace-
maker (PM) had been evaluated in several studies (Table 1).
The study of Dirks et al. investigated 5 patients with a
cardiac pacemaker who underwent CE [1]. In two patients
with an abdominal pacemaker, the authors screened the
patients for interference by placing the capsule on the
abdominal wall of the patient in proximity to the abdominal
PM. The PM was set in VVI mode for a back-up rate of
30bpm, and analysis for normal functioning was performed2 Diagnostic and Therapeutic Endoscopy
Table 1: Studies investigating patients with cardiac pacemakers who underwent capsule endoscopy.
Author Year
Number of
patients/cardiac
pacemakers (n)
Brand of cardiac
pacemaker Kind of study Interference Brand of CE
Dirks et al. 2008 5 No speciﬁcation In vivo No Given Imaging
Bandorski et al. 2008 21
Medtronic, Osypka,
Siemens, Vitatron, Ela,
Guidant, St. Jude Medical
In vitro No Given Imaging
+ Olympus
Bandorski et al. 2006 1 Biotronik In vitro No Given Imaging
Payeras et al. 2005 20 No speciﬁcation In vitro + In vivo No Given Imaging
+ Test Cap
Bandorski et al. 2005 45 No speciﬁcation In vivo No Given Imaging
Dubner et al. 2005 100
St. Jude Medical,
Medtronic, Guidant,
Biotronik, Sorin
In vivo Yes (n = 4, noise
mode) Given Imaging
Guyomar et al. 2004 1 ELA In vivo No Given Imaging
Leighton et al. 2004 5 No speciﬁcation In vivo No Given Imaging
with the magnetic programmer. All patients included in the
study were closely monitored for the duration of the CE in
their outpatient investigation unit. No adverse events were
documented, and the quality of the video was without any
interference.
Our in vitro study investigated 21 PMs from 7 brands
[2]. The pacemakers used for the investigation came from
a collective gathered over 4 years. They had mainly been
removed from deceased patients before cremation. All PMs
were tested for normal functioning. To electrically simulate
the situation of a pacemaker inside a patient, the PM and
its lead were positioned in a saline solution with a resistivity
corresponding to that of the lower frequency range of muscle
tissue, analogously to a study of Irnich et al. in which the
interference behaviour of mobile phones with respect to
PM was investigated [3]. Brieﬂy, a 0,9g/L saline solution
has been used. Its conductivity of 170mS/m (5,9Ωm
correspondingly) was chosen to simulate the low frequency
behaviour of tissue. The PM pulse was registrated with pin
jacks which were placed fairly low down at the bottom of
the tank. The jacks also allowed the input of an inhibiting
signal. At the beginning of the experiment, the sensitivity
settings were left as they had been in the patient. The
devices were then programmed to the maximum sensitivity.
First the pacemakers were checked while operating with an
unsynchronized impulse and a minimum distance between
PM and capsule which was placed, for 1 minute each time,
in diﬀerent positions and directions relative to the PM
and ﬁnally on the case of the PM. Then the pacemaker
was inhibited corresponding to the CENELEC standard test
signal. Measurements were then repeated with the capsule in
the diﬀerent positions and orientations for 1 minute each
time. The function of the capsule was registrated with the
aid of receiving electrodes and the data passed to a recording
device. None of the PM tested, in either the asynchronous
or synchronous mode, showed interference from a capsule.
Functioning of the capsule or the quality of the recorded
signal was not inﬂuenced by PM.
Previously we performed an in vitro study with one
pacemaker (Philos DR, Biotronik, Berlin, Germany) and CE
(Given Imaging) which was placed in a cleaned porcine
gut [4]. The gut was inserted in a horizontal direction
into a plastic bag ﬁlled with glucose solution. With the
eight sensors, the transmitting signals of CE were sent
to a receiving unit. The PM (DDD-Mode) was placed in
proximity of the gut/CE opposite to the electrodes. The
function of the PM was observed permanently. Finally an
electrodewiththecardiacpacemakerinVVI-Mode(uni-and
bipolar stimulation), was placed in the glucose solution near
the gut. An ECG was recorded for about 10 minutes. There
were no interferences between the CE and the PM in spite of
the close proximity of CE and PM.
The study of Payeras et al. had two phases, an in vitro
and an in vivo one. The objective of the in vitro study was
to investigate interference between CE and PM [5]. A PM
(Kappa KD 701, Medtronic, Minneapolis, MN, USA) was
connected to an interference detector which displays a graph
of PM rhythm. Possible interference between PM and CE
was tested for 1 minute with a TestCap (Given Imaging,
Yogneam, Israel), a device that transmits an indentical signal
as the endoscopic capsule (personal information of the
manufacturer) but without optical properties. First possible
interference between PM and CE was assessed in an air
medium and then with the pacemaker placed into a vessel
containing a solution, similar to the one used in our inves-
tigation. In each medium, the experiment was performed
twice, ﬁrst with the PM in a unipolar and then in a bipolar
mode. The authors did not exactly describe the procedure
of testing interference between CE and PM. In the in vivo
part ﬁrst a test capsule was placed close to the patient’s chest
andconsecutivelythepatientswallowedCE.Allpatientswere
connected to a Holter monitor for the duration of CE. None
of the PM was inﬂuenced by the TestCap or CE. No defects
in the quality of the images occurred in any patient.
A prospective inquiry in the year 2004 evaluated the
experience related to CE in patients with electrical implantsDiagnostic and Therapeutic Endoscopy 3
(PM/ICD) in Germany [6]. A standardized questionnaire
was sent to all centers in Germany performing CE. The ques-
tionairecoveredthenumberofexaminedpatients,indication
for CE, quality of CE videos, type of cardiac monitoring
duringCE,checkoftheelectricimplantsbeforeandafterCE,
occurrence of arrhythmia, and complications. In 28 centers,
45 patients with a PM and 8 patients with an ICD were
examined with CE. There were no relevant complications. In
only two cases, supraventricular extrasystoles were recorded.
In two patients with a PM, artifacts in the CE-video were
seen.
Dubner’s study is the only one with interference between
CE and PM. In this study, 100 patients with an implanted
PM were included [7]. The testing was performed with a
TestCap (technical properties identical to CE). Continuous
electrocardiographic monitoring was performed during the
study. The TestCap was placed above the pulse generator
and then manually moved along the course of the leads to
the atrial and ventricular tips. The test was performed 3
times, each time with the TestCap at a diﬀerent distance:
close (2cm), around 10cm from the skin surface and more
than 10cm from the surface for 10, 30, and 60 seconds.
Patients with interference were reevaluated one week later.
In this study interference was observed in 4 patients and was
reproducible 1 week later. The interference occurred when
the TestCap was localized within 10cm of the skin surface
close to the generator and the electrodes (manufactured
by St. Jude Medical, St. Paul, MN, USA and Biotronik,
Berlin, Germany) and caused the pacemaker to revert to
noise-mode function (VOO- or DOO-Mode). The PM were
programmed in bipolar sensing mode and there were no
diﬀerences in the sensitivity of these devices compared with
the PM for which testing was negative. The authors conclude
that the observed interference between TestCap simulation
and PMs in the setting of a “worst case senario” did not have
clinical relevance.
Guyomar et al. report about a patient with an abdominal
VVI-PM connected to an unipolar epicardial electrode after
an episode of endocarditis, which required the removal
of all preexistent prosthetic material [8]. First CE was
positioned over various abdominal sites near the pulse
generator (programmed in VVI mode), while ECG was
continuously recorded. No interference was recorded. Before
swallowing the CE, the PM was programmed to VOO-Mode
(70bpm). The patient was monitored by a central station
(telemetry?) for the duration of the endoscopy procedure.
Neither interference between CE and PM nor PM dysfunc-
tion during the examination was observed. However, the
CE-video revealed innumerable “blank periods” during the
ﬁrst half of the examination. The earliest study of Leighton
et al. investigated 5 patients [9]. Before the CE procedure,
an electrocardiogram was obtained and PM functions were
checked. During CE, cardiac rhythm was monitored with
a Holter ECG. After CE, PM function was checked for
any disturbance. Atrial and ventricular extrasystoles were
registered in 3 patients; one patient had a 3-beat-run of a
nonsustainedventriculartachycardia.PMfunctionswerenot
altered. There was no interference noted in the images.
3. Capsule Endoscopy in Patients with
Implantable CardioverterDeﬁbrillators
Several studies investigated patients with ICD who under-
went CE (Table 2). Additionally, our in vitro study investi-
gated interference between CE and ICD in vitro [10]. Two
reactions of ICDs with respect to continuous interference
are possible: the pacing pulses of the ICDs are inhibited
by the interference voltages, or the ICDs, if inhibited by
a test signal, operate in an asynchronous mode, the so-
called interference mode. This reaction is comparable to
that of pacemakers. In a pilot study, interference behaviour
was tested in 47 ICDs with respect to continuous 50Hz-
voltages coupled directly into the device. They all (except
the ﬁve Biotronik ICDs) came from a collection of ICDs
gatheredover4years,beingexplantedfromdeceasedpatients
before cremation. The manufacturer Biotronik supported
our investigation by providing ﬁve “Belos” ICDs. The 50Hz-
voltages were chosen because pacemakers and ICDs are
most sensitive to this interference voltage [11]. All other
interference voltage, thus, must have higher amplitudes than
that measured with 50Hz. The interference threshold was
tested with a signal generator producing continuous 50Hz
voltages that was coarsely increased from below threshold
to above threshold and then ﬁne-tuned to exact threshold.
A pilot study revealed that out of the 47 devices tested, 36
(77%) were inhibited (Group 1) whereas the remaining 11
(23%) elements were switched to asynchronous interference
mode (Group 2). Diﬀerentiation of the ICDs concerning
their interference behaviour in the two groups is necessary
for the following interference investigation with endoscopy
capsules.
A total number of 47 ICDs were included in this
investigation; two of them investigated in the pilot study
could not be used because of connector problems. The test
setting was created analogously to a study of Irnich et al.
in which the interference behaviour of mobile phones with
respect to pacemakers was investigated [3]. The ICDs and
theirlead(s)werepositionedinasalinesolutionof0.9%with
a resistivity corresponding to that of the low frequency range
of muscle tissue, to electrically simulate the situation of an
ICD inside a patient. Quite low at the bottom of the tank,
pin jacks were placed that were in contact with the solution.
By these jacks, the ICD pulse was registered, and signals
could be coupled in. The ICD pulses were registered by an
oscilloscope. For ICDs of Group 1, interference, if present,
should be characterized by inhibition of the pacing pulses.
For ICDs of Group 2, a triangular test signal according to the
European Standard EN 45502-2-1 (CEN/CENELEC) was
coupled in with the aid of a function generator to inhibit
the ICDs. Interference, if present, should be characterized
by asynchronous pacing. The ICDs of both groups were
checked with variable distances between ICD and capsules.
T h ec a p s u l e sw e r eh e l db yh a n di nd i ﬀerent positions
and directions to the ICD for 1 minute each. Finally, the
capsules were placed directly on the case of the ICD for 1
minute. Attention was paid to possible interference eﬀects.
In addition, the capsules were positioned for 1 minute
close to the tip, ring, and coil of the lead while the device4 Diagnostic and Therapeutic Endoscopy
Table 2: Studies investigating patients with implantable cardioverter deﬁbrillators who underwent capsule endoscopy.
Author Year
Number of
patients/ICD
(n)
Brand of ICD Kind of study Interference Brand of CE
Bandorski et al. 2009 45 Biotronik, Guidant,
Medtronic, St. Jude Medical In vivo No Given Imaging
+ Olympus
Dubner et al. 2008 6( I nv i t r o )
6( I nv i v o )
Medtronic, St. Jude
Medical, Guidant,
Biotronik
In vitro + In vivo Yes
No Given Imaging
Pelargino et al. 2005 1 Medtronic In vivo No Given Imaging
Bandorski et al. 2005 8 No speciﬁcation In vivo No Given Imaging
Leighton et al. 2005 5 Guidant, Medtronic, St.
Jude Medical In vivo No Given Imaging
was operating in asynchronous (Group 1) or synchronous
(Group 2) mode. Function of capsules was recorded with the
aid of receiving electrodes distributed on the body surface,
and the data were passed to a recording device. During the
whole investigation, the function of the ICDs was checked by
registering the pacing pulses with an oscilloscope. None of
the ICDs, operating in asynchronous or synchronous mode,
showed interference caused by a capsule, or, in other words,
no dysfunction of the ICDs of both groups was detected.
This holds for all positions of the capsules with respect to
the lead and the ICD devices investigated. No interactions
between the capsules and the ICDs were seen. For the entire
duration of our experiment, an undisturbed signal was
sent by the capsules. In spite of the proximity between the
capsules and the ICD, the function of the capsules or the
quality of the recorded signal was not aﬀected at all.
Similar to their ﬁndings in patients with PM, Dubner et
al. reported about interference between CE and ICD [12].
T h e yp e r f o r m e das t u d yw i t ha ni nv i t r oa n da ni nv i v o
part. For the in vitro part, they placed an ICD and its lead
into a saline gel bath with a controlled temperature of 98◦F.
The probe associated with the TestCap (technical properties
identical to CE, Given Imaging) was positioned close to
the bath at speciﬁed distances and locations with respect to
the ICDs. Tests were carried out at the nominal and most
sensitive setting of the ICDs. The TestCap was located 1, 5,
10, and 15 centimeters from the ICD over three diﬀerent
positions (ring, coil, pulse-generator) during 10, 30, and 60
seconds. ICDs were checked before and after the test with
speciﬁc programmers. To conﬁrm the results and avoid false
negative/positiveresults,testswereperformedoneweeklater.
There was no inhibition of the brady therapy. Positive and
reproducible interference (oversensing) was observed when
theTestCapwasplacedovertheringandthecoilbutnotover
the pulse generator (Belos DR, Biotronik, Gerlin, Germany).
Oversensing (triggering delivery of inappropriate therapy)
could not be eliminated even at a distance of 30cm from
the ICD system. The in vivo part of the study investigated
6 ICD patients with devices that showed no interference
during the in vitro study. Each ICD system was evaluated
similar to the in vitro part. The ICDs were programmed
to the manufacturers’ nominal and most sensitive settings.
The TestCap was located 1, 5, 10, and 15 centimeters to
the skin each in three diﬀerent positions (ring, coil, pulse-
generator) during 10 and 30 seconds. The 60 second period
was excluded by the authors for safety reasons. The ICDs
tested in the in vivo part showed no interference.
Pelargonio et al. published a case report on the applica-
tionofCEinapatientwithanICD(Medtronic,Minneapolis,
MN, USA, GEM III 7275) [13]. Before and after CE, the ICD
was interrogated. During CE, ECG was continuously mon-
itored. No arrhythmia or other adverse cardiac events were
recorded.Theprogrammedparameterswerenotaltered,and
no interference was found between CE and the ICD.
Our inquiry in the year 2004 (mentioned above) also
evaluated the experience of CE in patients with electrical
implants (PM/ICD) in Germany [6]. Eight patients with
an ICD underwent CE without evidence for interference
between ICD and CE.
The ﬁrst case series on patients with an ICD who
underwent CE was published by Leighton et al. [14]. Five
patientswithICDswerestudied.BeforeCE(GivenImaging),
all patients had a baseline ECG and an ICD interrogation.
Thereafter, CE was performed. During CE the patients were
monitored by telemetry during CE. A postprocedure ICD
interrogation was carried out. In all patients, normal ICD
functions and programmed parameters were not altered.
Hemodynamicallysigniﬁcantarrhythmiaswerenotobserved
in any of the patients. The CE images were reviewed. There
were no technical diﬃculties, and no interference was seen in
the images.
4. Capsule Endoscopy in Patients with
VentricularAssistDevices
Two case reports about patients with a left ventricular assist
device (LVAD) who underwent CE are published in Medline.
Girelli et al. report about 42-year-old patient with a
history of an idiopathic dilatative cardiomyopathy, which
was refractory to medical treatment [15]. An LVAD, Heart
INCOR (Berlin Heart AG, Berlin, Germany), was implanted
asabridgetotransplantation.Underatherapywithwarfarin,
aspirin, and low molecular weight heparin the patient
suﬀered from melena. As upper and lower gastrointestinalDiagnostic and Therapeutic Endoscopy 5
endoscopy, splanchnic arteriography and tagged red blood
cells scan were unrevealing. CE was performed. The parame-
ters of LVAD were monitored during CE. No hemodynamic,
electronic, or mechanical abnormalities or malfunction were
observed. The video of CE was unaﬀected.
Another case of a 45-year-old man with an LVAD
(INCOR; Berlin Heart AG, Berlin, Germany) who suﬀered
likewise from a dilatative cardiomyopathy was reported by
Garattietal.[16].AfterimplantationoftheLVADthepatient
developed melena. Numerous blood transfusions were nec-
essary. Because upper and lower gastrointestinal endoscopy,
catheterisation of superior and inferior mesenteric artery
a n dt a g g e dr e db l o o dc e l l ss c a nw e r eu n a b l et od e t e c ta
bleeding source. CE was performed. CE failed to reveal
actively bleeding lesions. However, gastrointestinal bleeding
did not recur after cardiac transplantation. The authors did
not ﬁnd any interference between CE and the Incor LVAD.
5. Discussion
5.1.CapsuleEndoscopyandCardiacPacemakers. Interference
between CE and PM was investigated in 8 studies. In our
second in vitro study [2], we simulated the situation of a
pacemakerinsideapatient,analogouslytoastudyofIrnichet
al. investigating the interference behaviour of mobile phones
with respect to PM [3]. This setting is equivalent to a patient
in contrast to the setting in our ﬁrst in vitro study [4]
and perhaps the study of Payeras with missing description
of the concentration of saline solution [5]. Although it is
problematic that the TestCap in the studies of Dubner and
Payeras was located not in direct contact with the skin
surface/into the saline solution causing that the setting is not
equal to the circumstances inside a patient.
The study of Guyomar reports about a patient with an
abdominal pacemaker programmed to VOO-Mode before
swallowing CE [8]. This setting is problematic because the
VOO-Mode is an interference mode. Interference between
telemetry and CE could possibly explain loss of images in
thisstudy.DisturbanceofaCEvideocausedbysimultaneous
telemetry was registered in an own multicenter survey [17].
Interference might be explained by the fact that many
wireless applications like some telemetry use the same
frequency as CE.
Most studies preferred monitoring for the whole time of
CE. In Dubner’s study, interference occured within the ﬁrst
10 seconds [7]. From a physical point of view it is clear that
interference occurs at once or not. Because of this fact, long-
term monitoring is not necessary.
It has been argued by Payeras et al. [5] that a bipolar
mode minimizes the risk of interference between CE and
PM and that bipolar pacemakers would be resistant to inter-
ference from mobile phones (frequency: CE Given Imaging
434.09MHz, CE Olympus 433.8MHz, C-Net mobile phone
450MHz) [18]. Irnich et al. investigated 44 Medtronic
models in bipolar and unipolar mode and demonstrated
that 5 out of 27 unipolar systems (18,5%) and 4 out of
17 (23,5%) bipolar systems were susceptible [3]. In another
study, interference was only seen in patients with bipolar
pacemakers [7]. The reason for interference (no interference
in our study) between the “Actros” (Biotronik, Berlin,
Germany) in the study by Dubner remains unclear, and the
results seem to be physically rather dubious.
Relating to possible interference between CE and
PM/ICD we contacted the manufacturer Given Imaging.
Technical data of CE were made available to the ﬁrst
author of this paper and Prof. Dr. Silny (Head of the
Forschungszentrum f¨ ur Elektro-Magnetische Umweltver-
tr¨ aglichkeit, RWTH Aachen) after signature of a nondisclo-
sure agreement. On the basis of these data Prof. Dr. Silny
concluded that an interference between CE (Given Imaging)
and PM/ICD is impossible from technical site even CE and
PM/ICD are in close proximity (written statement of Prof.
Dr. Silny).
Twoothertypesofcapsuleendoscopesareonthemarket.
The OMOM capsule (Jinshan, Chongqing, China) has a
similar transmission of images by radio frequency [19].
However, no data are available yet on the safety of this
system in patients with pacemaker/ICDs. In contrast, the
MiRo Cam (Intromedic, Seoul, Korea) is based on a totally
diﬀerent system of electric ﬁeld propagation [20]. Images are
transferred via 3V current by using the human body as a
conductortogetherwithstandardECGelectrodesattachedto
theabdomen.Forthissystem,systematicstudiesarerequired
before application in patients with pacemaker/ICDs.
Further developments of wireless capsule endoscopy
systems include remote control of capsule functions via the
recorder. The OMOM small bowel system enables manual
switching between image acquisition rates, for example, for
a power saving mode during gastric passage [21]. PillCam
Colon2 provides automatic frame rate control (4 versus
39 images/sec.) depending on the speed of the capsule
as represented by the changes of images [22]. Although
interference with implanted cardiac devices is as unlikely as
withsignalsentfromthecapsule,nodatahasbeenpublished
yet on in vitro or in vivo evaluation.
Anewcapsuleendoscopysystem,presentlyunderclinical
evaluation (Capsovision, Saratoga, CA, USA) stores acquired
image data on an internal chip. In consequence, the capsule
has to be retrieved. On the other hand, by completely
avoiding emission of current or radiofrequency waves, there
is no possibility for potential interaction with implanted
cardiac devices.
5.2. Capsule Endoscopy and Implantable Cardioverter Deﬁb-
rillators. Our investigation for interference between CE and
ICD is the only one testing interference behaviour of
ICDs [10]. As described above, the setting was chosen to
electrically simulate the situation of a pacemaker inside
a patient. The study of Dubner et al. used a “saline gel
bath” without speciﬁcation of the concentration of the saline
solution. The TestCap and the saline solution/skin of the
patient were not in direct contact in this study too [11].
One ICD, the “Belos” (Biotronik, Berlin, Germany), showed
interference with CE (TestCap located up to 30cm from the
ICD) when the TestCap CE was placed over the ring and coil
but not over the generator. This observation is inconsistent
with a previous study of Dubner with interference between
C Ea n dP Mi fC Ew a sl o c a t e di nc l o s ep r o x i m i t y( <10cm)6 Diagnostic and Therapeutic Endoscopy
to the pacemaker generator [7]. In our study, no interference
was noticed between CE and the “Belos” [10].
Based on the technical data of CE and impossibility
of interference between CE and PM/ICD, the reported
interference must be related to other (local) reasons.
5.3. Capsule Endoscopy and Left Ventricular Assist Devices.
Two case reports not report about interference between CE
and LVAD. A multicenter US series investigation from the
MayoClinic ScottsdalerevealedinterferencebetweenCEand
LVAD in 2 patients [23]. The reason for this interference is
not commented on by the authors. Perhaps the patients were
monitored with telemetry.
6. Conclusion
(1) There are unconﬁrmed reports on possible inter-
ference of an electromagnetic device for simulation
of capsule endoscope transmission (Given Imaging)
on cardiac pacemakers and implantable cardioverter
deﬁbrillators in a setting of maximal susceptibility.
However, other in vitro studies, theoretical con-
siderations, and an increasing number of clinical
observations support that there is no risk for patients
with cardiac devices undergoing CE with the Given
smallbowelsystem.Preliminarydatasuggestthatthis
might also be applicable for the Olympus system and
for patients with left ventricular assist devices.
(2) Further studies on OMOM capsule, MiRo Cam, and
the remote controllable PillCam Colon2 are needed.
(3) Interference between telemetry and impairment of
CE video by wireless telemetry and left ventricular
assist devices is possible.
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